Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Large Molecule (3)
254 Articles Available
3
11
Can't find what you're looking for? Try our
advanced search
.
Quality
Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status
PAO-06-21-CL-12
Collaboration
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
PAO-06-21-CL-02
Viral Inactivation
Continuous Inline Viral Inactivation for Next-Generation Bioprocessing
PAO-05-21-CL-06
Capacity Expansion
German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand
PR-M05-21-008
Microbial Fermentation
The Enduring Usefulness of Microbial Fermentation
PAO-04-22-R221-26
Biopharma
Assessing the Dynamic Market for Biologics
PAO-04-22-R221-23
Partnership
BioVectra and PhaseBio Discuss Creating an Optimal Partnership
PTV-04-21-CL-001
Oncology
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
PR-M04-21-001
Animal-Free Manufacturing
Nu-Tek BioSciences to Build Dedicated Animal-free Peptone Manufacturing Facility to service Growing Biologics Supply Chain Demands
PR-M11-20-043
Single-Use Technology
Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT
PAP-Q4-20-CL-004
The Future of Healthcare
How Does Polpharma Biologics Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-010
FDA Authorization
Babson Diagnostics Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test
PR-M11-20-025
Antibodies
Lilly's Neutralizing Antibody Bamlanivimab (LY-CoV555) Receives FDA Emergency Use Authorization for the Treatment of Recently Diagnosed COVID-19
PR-M11-20-023
Antibodies
Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies
PR-M11-20-022
M&A
AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million
PR-M11-20-018
Licensing
ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences
PR-M11-20-004
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
PAP-Q3-20-CL-008
Clinical Supply
Getting Your Biologic to Clinic Faster and More Efficiently
PAP-Q3-20-CL-011
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
PAP-Q2-20-NI-001
FDA Antibody Tests
FDA Provides Promised Transparency for Antibody Tests
COVID-19 Antibody Testing
Roche's Highly Accurate Antibody Test for COVID-19 Goes Live at More than 20 Initial Lab Sites in the U.S.
PR-M05-20-NI-035
GSK's Asthma Biologic Approved
PR-M04-20-NI-007
Facility
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
PR-M03-20-NI-019
Biologics
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products
PR-M02-20-NI-016
«
3
11
»
.svg)